Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
NCT Number: NCT01428739
Correlation between MRS and Tumor Response Therapy in Breast Cancer.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Edmonton, Alberta, T6G 1Z2, Canada
Correlation between MRS (Magnetic Resonance Spectroscopy and Tumor Response to Radiation in Breast Cancer
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Procedure
Other names: Philips 3 Tesla MRI Scanner
Time frame: Up to One Year
measuring choline, water and fat levels by proton magnetic resonance spectroscopy in breast tumors in response to treatment
Time frame: Up to One year
AHS Cancer Control Alberta
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02009449
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT06096623
Breast Cancer, Breast Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT03051828
Breast Cancer, Breast Diseases
Cergy-Pontoise, France
View Trial Details